BAX mutations and cancer patient survival.
TGFβRII mutations are also shown for
comparative purposes. No correlation was found between
BAX mutations and other clinical or histopathological
parameters, including the age, gender, differentiation degree,
anatomical localization, or invasiveness of the tumors. The presence of
BAX mutations thus appears to be an independent
indicator of poor prognosis.